Quantum Computing Startup Zurich: €28M Funding Round

In a funding round that underscores Zurich's evolving role as a deep-tech powerhouse, QuantumBridge Technologies has closed a €28 million Series B investment led by European and US venture firms. The announcement, made quietly this month from offices in the Europaallee development zone, marks a turning point for Switzerland's quantum computing ecosystem—one that has long lived in the shadow of Silicon Valley's flashier announcements but is now attracting serious capital.

QuantumBridge, founded by three former ETH Zurich researchers, focuses on quantum error correction—the engineering problem that has stymied quantum computing's commercial viability for years. Rather than chasing raw qubit counts, the team is solving the unglamorous but essential challenge of making quantum systems reliable enough for real-world applications in pharmaceuticals, materials science, and financial modelling.

The round is notable for a few reasons. First, it reflects a shift in investor appetite. Two years ago, quantum startups were struggling to raise Series B funding as the hype cycle cooled. QuantumBridge's success suggests that VCs are now backing teams with genuine technical depth and near-term commercialisation paths. Second, the lead investors—including firms based in Zurich's own venture community—indicate that local capital is becoming increasingly sophisticated about deep tech. This wasn't always the case.

For Zurich's broader startup ecosystem, the implications are significant. The city has long punched above its weight in biotech and fintech, but quantum computing represents a new frontier. ETH Zurich's physics and computer science departments have been producing world-class talent for decades; until recently, most of that talent left for Stanford, MIT, or Cambridge. QuantumBridge's success—and its decision to stay rooted in the Zurich region rather than relocate to the US—suggests the retention equation is shifting.

The funding will go towards scaling the team from 18 to 35 people and moving from proof-of-concept to beta partnerships with industrial clients. Three major pharmaceutical firms are already running pilots on QuantumBridge's systems, though the startup is under strict non-disclosure agreements about the details.

Zurich's venture scene remains small compared to London or Berlin—total early-stage funding in the canton last year was around €850 million—but it's consolidating around quality rather than volume. QuantumBridge's round exemplifies this trend: meaningful capital chasing genuine innovation, not just the next copy-paste SaaS play. For founders and investors watching the city's deep-tech trajectory, this month's news is worth paying attention to.

This article was compiled by AI and screened before publishing. See our editorial standards.